These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 22137044)

  • 1. Ethical considerations of biomarker use in neurodegenerative diseases--a case study of Alzheimer's disease.
    Prvulovic D; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):517-9. PubMed ID: 22137044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The future of Alzheimer's disease: the next 10 years.
    Hampel H; Prvulovic D; Teipel S; Jessen F; Luckhaus C; Frölich L; Riepe MW; Dodel R; Leyhe T; Bertram L; Hoffmann W; Faltraco F;
    Prog Neurobiol; 2011 Dec; 95(4):718-28. PubMed ID: 22137045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and management of Alzheimer's disease: past, present and future ethical issues.
    Gauthier S; Leuzy A; Racine E; Rosa-Neto P
    Prog Neurobiol; 2013 Nov; 110():102-13. PubMed ID: 23578568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers for Alzheimer's disease and other forms of dementia: clinical needs, limitations and future aspects.
    Cedazo-Minguez A; Winblad B
    Exp Gerontol; 2010 Jan; 45(1):5-14. PubMed ID: 19796673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical issues in Alzheimer's disease: an overview.
    Leuzy A; Gauthier S
    Expert Rev Neurother; 2012 May; 12(5):557-67. PubMed ID: 22550984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Experts' opinions on ethical issues of genetic research into Alzheimer's disease: results of a Delphi study in the Netherlands.
    van der Vorm A; van der Laan AL; Borm G; Vernooij-Dassen M; Olde Rikkert M; van Leeuwen E; Dekkers W
    Clin Genet; 2010 Apr; 77(4):382-8. PubMed ID: 20002460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ethical considerations in the presymptomatic diagnosis of Alzheimer's disease].
    Kessel Sardiñas H
    Rev Esp Geriatr Gerontol; 2011 Oct; 46 Suppl 1():55-9. PubMed ID: 22152917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the early detection of Alzheimer's disease.
    Nestor PJ; Scheltens P; Hodges JR
    Nat Med; 2004 Jul; 10 Suppl():S34-41. PubMed ID: 15298007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant animal models.
    Reddy PH; McWeeney S
    Neurobiol Aging; 2006 Aug; 27(8):1060-77. PubMed ID: 16157420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical proteomics in neurodegenerative disorders.
    Zetterberg H; Rüetschi U; Portelius E; Brinkmalm G; Andreasson U; Blennow K; Brinkmalm A
    Acta Neurol Scand; 2008 Jul; 118(1):1-11. PubMed ID: 18279484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers for major depression and its delineation from neurodegenerative disorders.
    Schneider B; Prvulovic D; Oertel-Knöchel V; Knöchel C; Reinke B; Grexa M; Weber B; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):703-17. PubMed ID: 21854829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention trials in Alzheimer's disease: an EU-US task force report.
    Vellas B; Aisen PS; Sampaio C; Carrillo M; Scheltens P; Scherrer B; Frisoni GB; Weiner M; Schneider L; Gauthier S; Gispen-de Wied CC; Hendrix S; Feldman H; Cedarbaum J; Petersen R; Siemers E; Andrieu S; Prvulovic D; Touchon J; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):594-600. PubMed ID: 21925234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations for best practices in the treatment of Alzheimer's disease in managed care.
    Fillit HM; Doody RS; Binaso K; Crooks GM; Ferris SH; Farlow MR; Leifer B; Mills C; Minkoff N; Orland B; Reichman WE; Salloway S
    Am J Geriatr Pharmacother; 2006; 4 Suppl A():S9-S24; quiz S25-S28. PubMed ID: 17157793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Looking backward to move forward: early detection of neurodegenerative disorders.
    DeKosky ST; Marek K
    Science; 2003 Oct; 302(5646):830-4. PubMed ID: 14593169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ethical and legal issues in late stage of dementia].
    Fernandes L
    Acta Med Port; 2008; 21(1):65-71. PubMed ID: 18489837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early diagnostic accuracy and pathophysiologic relevance of an autopsy-confirmed Alzheimer's disease peripheral biomarker.
    Khan TK; Alkon DL
    Neurobiol Aging; 2010 Jun; 31(6):889-900. PubMed ID: 18760507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is late-onset schizophrenia related to neurodegenerative processes? A review of literature].
    Lagodka A; Robert P
    Encephale; 2009 Sep; 35(4):386-93. PubMed ID: 19748376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease.
    Prvulovic D; Bokde AL; Faltraco F; Hampel H
    Prog Neurobiol; 2011 Dec; 95(4):557-69. PubMed ID: 21722703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perspective on future role of biological markers in clinical therapy trials of Alzheimer's disease: a long-range point of view beyond 2020.
    Hampel H; Lista S; Teipel SJ; Garaci F; Nisticò R; Blennow K; Zetterberg H; Bertram L; Duyckaerts C; Bakardjian H; Drzezga A; Colliot O; Epelbaum S; Broich K; Lehéricy S; Brice A; Khachaturian ZS; Aisen PS; Dubois B
    Biochem Pharmacol; 2014 Apr; 88(4):426-49. PubMed ID: 24275164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.